Annual Review of Biomedical Data Science

The Annual Review of Biomedical Data Science is an annual review journal published by Annual Reviews since 2018, presenting comprehensive expert reviews of computational, statistical and artificial intelligence approaches to biomedical data, with a 2025 Journal Impact Factor of 8.1 and a first-quartile rank of 2 of 67 in mathematical and computational biology《生物医学数据科学年鉴》（Annual Review of Biomedical Data Science）是（Annual Reviews）自 2018 年起出版的年鉴型综述期刊，刊载计算、统计与人工智能方法处理生物医学数据的综合性专家综述，2025 年影响因子为 8.1，在数学与计算生物学类 67 种期刊中列第 2 位，居第一四分位。

Scope

• The journal provides comprehensive expert reviews in biomedical data science, focusing on advanced methods to store, retrieve, analyze and organize biomedical data and knowledge该刊提供生物医学数据科学领域的综合性专家综述，重点介绍生物医学数据与知识在存储、检索、分析与组织方面的先进方法。
• Its scope encompasses informatics, computational, artificial intelligence and statistical approaches to biomedical data, including bioinformatics, computational biology, biomedical informatics, clinical and clinical research informatics, biostatistics and imaging informatics其覆盖范围包括面向生物医学数据的信息学、计算方法、人工智能与统计方法，具体含生物信息学、计算生物学、生物医学信息学、临床与临床研究信息学、生物统计学以及影像信息学。
• Articles are commissioned expert reviews organised into thematic volumes rather than reports of primary research, with each volume addressing a set of method-oriented topics该刊文章为邀约撰写的专家综述，按主题分卷组织，而非原创研究报告；每卷围绕一组以方法为核心的主题。
• Under the publisher's Subscribe to Open programme the current volumes are published open access when institutional subscriptions are sufficient, and content is also offered to developing countries through Research4Life在出版方的（Subscribe to Open）机制下，若机构订阅量足够，当年卷即以开放获取方式出版；该刊内容还通过（Research4Life）向发展中国家提供。
• It is indexed in the Science Citation Index Expanded and Scopus, and its articles carry the digital object identifier prefix 10.1146该刊被（SCIE）与（Scopus）收录，文章的数字对象唯一标识符前缀为（10.1146）。
• The journal is published by Annual Reviews, a non-profit publisher based in Palo Alto, California, which has issued critical review series since 1932该刊由（Annual Reviews）出版，后者是位于美国加州帕洛阿尔托的非营利出版机构，自 1932 年起出版综述系列。

History

• The Annual Review of Biomedical Data Science was launched in 2018, with its first volume published in July of that year, extending the Annual Reviews portfolio into the emerging field of biomedical data science该刊于 2018 年创办，首卷于当年 7 月出版，将（Annual Reviews）的综述系列延伸至新兴的生物医学数据科学领域。
• Its founding and current Editor-in-Chief is Russ B. Altman of Stanford University, who has held the post since 2016 and guided the journal from planning into publication创刊主编亦即现任主编为斯坦福大学的 Russ B. Altman，他自 2016 年起担任该职，并主导了从筹备到出版的整个过程。
• Volumes have appeared annually since launch, with Volume 1 in 2018, Volume 8 in 2025 and Volume 9 in 2026该刊自创刊起每年出版一卷，2018 年为第 1 卷，2025 年为第 8 卷，2026 年为第 9 卷。
• Since 2023 the publisher has been converting the current volumes of its journals to open access through Subscribe to Open, and the 2024 and 2025 volumes were both published as open access自 2023 年起，出版方通过（Subscribe to Open）机制将其期刊的当年卷转为开放获取，2024 年与 2025 年卷均以开放获取方式出版。
• Its Journal Impact Factor was 6.0 in 2024 and rose to 8.1 in 2025, and the journal is among the highest-ranked titles in mathematical and computational biology其影响因子 2024 年版为 6.0，2025 年版升至 8.1，在数学与计算生物学类别中位居前列。

Editors

• The Editor-in-Chief is Russ B. Altman, Kenneth Fong Professor of Bioengineering, Genetics, Medicine and Biomedical Data Science at Stanford University, whose interests include pharmacogenomics, biomedical informatics and artificial intelligence in medicine现任主编 Russ B. Altman 为斯坦福大学生物工程、遗传学、医学与生物医学数据科学的 Kenneth Fong 讲席教授，研究兴趣包括药物基因组学、生物医学信息学与医学人工智能。
• Each volume is planned by the Editor-in-Chief together with an editorial committee whose members rotate and cover the sub-fields represented in the journal每卷的选题由主编与编辑委员会共同规划，委员会成员轮换，覆盖该刊涉及的各个子领域。
• Articles are commissioned from invited experts and pass through peer review before publication, which keeps the journal's content review-based rather than submission-driven文章由编辑邀请领域专家撰写，并在出版前经同行评审，因此该刊内容以综述为主而非以自由投稿为主。
• The editors enforce the publisher's policies on competing interests, research integrity and the independence of the review process编辑执行出版方关于利益冲突、研究诚信与评审独立性的各项政策。
• Editorial correspondence is handled by the publisher's editorial office, which also administers the journal's open access arrangements and library agreements编辑事务由出版方编辑部处理，并负责该刊的开放获取安排与图书馆协议。